2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities and Gene Therapies 2024 | American Conference Institute | 19 March 2024 | Seaport Hotel Boston, 1 Seaport Ln, Boston, MA 02210, USA

Leveraging Technology, Safeguarding IP, and Securing Funding to Accelerate Development in mRNA, CRISPR and CAR T

This events provide you with solutions to some of the greatest challenges impeding market access for these products.

We were pleased to have representatives from the USPTO and FDA, as well as, distinguished in-house and outside counsel, that discussed IP and regulatory initiatives that are essential to the proliferation of mRNA, CRISPR, CAR T and more.

2024 Speakers

CO-CHAIRS:

Cristin Berkey
Senior Director, IP and Contracts Counsel, Abata Therapeutics

Forrester Liddle
Head of Intellectual Property and Legal, US R&D, Novo Nordisk

Adrian Looney
Chief Intellectual Property Counsel, Vertex Pharmaceuticals

KEYNOTE SPEAKERS:

Julie Tierney
Deputy Center Director for Strategy, Policy and Legislation, Center for Biologics, FDA

SPEAKERS:

Jonathan S. Caplan
Partner Co-Chair, Intellectual Property, Kramer Levin Naftalis & Frankel LLP

Elbert Chiang
VP, IP, Beam Therapeutics

Jennifer Fang
Partner, Wilson Sonsini Goodrich & Rosati

Emily Gardel
Associate Director, Patent Attorney II, Dyno Therapeutics

Ryan Hagglund
Partner, Loeb & Loeb LLP

Margaux J. Hall
Partner, Ropes & Gray LLP

Michael B. Harlin
Partner, Neal, Gerber & Eisenberg LLP

Lisa Hillman
Partner, Lathrop GPM

Matt Karlyn
Partner, Morrison & Foerster LLP

Nishla H. Keiser
Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Roger Kuan
Partner, Norton Rose Fulbright

JM Lee
Director, Business Development, Novo Nordisk

Geoffrey Levitt
Head of Global Regulatory Law, argenx US, Inc.

Dan Liu
Attorney, Loeb & Loeb LLP

Gabriel J. McCool
VP, Legal and IP, ReNAgade Therapeutics

David M. McIntosh
Partner, Ropes & Gray LLP

Paul A. Ragusa
Partner, Baker Botts L.L.P.

Charles G. Raver
Attorney, Hyman, Phelps & McNamara PC

Matthew Rizzo
General Partner, OrbiMed Advisors LLC

Ashley Ross
Partner, Kirkland & Ellis LLP

Irena Royzman
Partner, Head of Life Sciences, Kramer Levin Naftalis & Frankel LLP

Chuck Sholtz
VP, IP, Nutcracker Therapeutics

David Silverstein
Vice President, Intellectual Property, Rocket Pharmaceuticals, Inc.

Julie Tierney
Deputy Center Director for Strategy, Policy and Legislation, Center for Biologics, FDA

Mary Till
Senior Legal Advisor, Office of Patent Legal Administration, USPTO

Jennifer Tousignant
Senior Vice President, Legal, Sana Biotechnology

Rebecca K. Wood
Partner, Sidley Austin LLP (Former Chief Counsel, FDA)

Olga Zimmerman
Director, Intellectual Property, Caribou Biosciences, Inc.

2024 Sponsors

SUPPORTING SPONSORS:
• Kramer Levin
• Ropes & Gray

ASSOCIATE SPONSOR:
• Neal Gerber Eisenberg

COCKTAIL RECEPTION SPONSOR:
• Loeb & Loeb llp